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  Resumen del Trabajo (máximo 250 palabras): Con la finalidad, contexto de 
aplicación, metodología, resultados i conclusiones del trabajo. 
La depresión es un trastorno mental cada vez más común asociado con déficits 
sustanciales en la calidad de vida del paciente y un mayor riesgo de 
mortalidad. Se han realizado varios estudios de asociación genómica (GWAS) 
para identificar genes asociados con la depresión, pero su heredabilidad 
parcial entre otras características sugiere la existencia de cambios 
epigenéticos en el origen de la enfermedad. Dado que se ha demostrado una 
discrepancia entre la cognición objetiva y subjetiva en pacientes con trastorno 
depresivo mayor (MDD), es necesario encontrar un sistema para detectar la 
enfermedad desde una perspectiva biológica. 
Utilizando una cohorte basada en una comunidad canadiense (n = 94) que 
contiene datos de metilación del ADN, estratificada para el estado 
socioeconómico temprano y evaluada para síntomas depresivos con la escala 
para Depresión del Centro para Estudios Epidemiológicos (CES-D), se realizó 
un análisis de metilación diferencial. A partir de este análisis, se identificaron 
31 dinucleótidos citosina-guanina (CpG) como metilados diferencialmente en 
pacientes que muestran síntomas depresivos contra pacientes que no 
muestran esos síntomas. El análisis se realizó separando a los pacientes por 
género y tomando la variable edad como una covariable. 
A partir de las variables socioeconómicas y biomoleculares, y los sitios de CpG 
identificados, se desarrolló un clasificador Random Forest con el objetivo de 
crear una herramienta de predicción de síntomas depresivos. El algoritmo 
resultante tiene una precisión del 73,74% (validación 15 veces cruzada con 3 
repeticiones). 
La aplicación web Desypre (http://desypre.000webhostapp.com/) se creó para 
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permitir el uso público del clasificador. 
  Abstract (in English, 250 words or less): 
Depression is an increasingly common mental disorder associated with 
substantial deficits in the quality of life of the patient and increased mortality 
risk. Several Genomic-Wide Association Studies (GWAS) have been performed 
to identify genes associated with depression, but its partial heritability among 
other characteristics suggests the involvement of epigenetic changes in the 
origin of the disease. Since has been proven a discrepancy between objective 
and subjective cognition in Major Depressive Disorder (MDD) patients, it is 
necessary to find a system to detect the disease from a biological perspective. 
Using a Canadian community-based cohort (n=94) containing DNA methylation 
data, stratified for early-life socioeconomic status, and assessed for depressive 
symptoms with the Center for Epidemiologic Studies Depression (CES-D) 
scale, a differential methylation analysis was performed. From this analysis, 31 
cytosine guanine dinucleotides (CpG) were identified as differentially 
methylated in patients showing depressive symptoms from patients not showing 
those symptoms. The analysis was performed separating patients by gender 
and taking the variable age as a covariate.  
From the socioeconomic and biomolecular variables, and identified CpG sites, 
a random forest classifier was developed to create a depressive symptoms 
prediction tool. The resulting algorithm has an accuracy of 73.74% (repeated 
15-fold cross-validation, with 3 repeats).  
The web application Desypre (http://desypre.000webhostapp.com/) was 
created to allow the public use of the classifier. 
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1. Introduction 
 
1.1 Context and justification of the project 
1.1.1 Depression 
Depression is an increasingly common mental disorder, with more than 320 
million patients of all ages in the world by 2015 [1]. The total estimated number 
of people living with the disorder increased by 18.4% between 2005 and 2015 
[2].  
MDD is associated with substantial deficits in the quality of life of the patient [3], 
suffering a combination of several symptoms (Table 1). Besides, it has a major 
impact on mortality risk: depressed men and women are 20.9 and 27 times, 
respectively, more likely to commit suicide than the general population. But it 
also increases the risk of other kinds of decease, such as cardiovascular death. 
Because of being a disorder that profoundly affects different levels in the life of 
the patient (functional, social, economic), it is predicted to become a major 
health burden worldwide [4]. 
 
Major depressive disorder  
5 or more of the following symptoms (including at least 1 of either 
depressed mood or loss of interest) in the same 2-week period 
• Depressed mood or persistent sadness 
• Loss of interest or pleasure in activities 
• Change in weight or appetite 
• Insomnia or hypersomnia 
• Psychomotor retardation or agitation 
• Loss of energy or fatigue 
• Feelings of worthlessness or guilt 
• Impaired concentration or indecisiveness 
• Thoughts of death or suicidal ideation or suicide attempt 
Table 1. American Psychiatric Association Diagnostic and Statistical 
Manual (DSM-V) criteria for major depressive disorder [5]. 
 
1.1.2 Epigenetics in depression 
MDD exhibits numerous non-Mendelian features that can be reviewed from an 
epigenetic perspective, such as partial heritability (approximately 37%), the 
discordance of monozygotic (MZ) twins and sexual dimorphism with more 
incidence in women than men [6]. Moreover, it has been suggested that 
environmental factors, e.g. low socioeconomic status (SES) in early life, trigger 
epigenetic changes that may increase the risk for future depression [7].  
 
What are those epigenetic changes? 
The most accessible and characterized form which epigenetic information in 
humans can be transmitted is via DNA methylation (DNAm, Figure 1) [8]. In 
somatic cells, DNAm occurs almost exclusively on cytosine residues in the 
context of CpGs. There are about 28 million CpG motifs non-randomly 
distributed across the haploid human genome [9]. The promoter regions of 60-
70% of all human genes contain CpG islands, which are areas with a higher 
concentration of CpG motifs, and their methylation regulates the gene 
2 
expression [10]. 
 
 
Figure 1: A) Fragment of DNA with methylated cytosines in the CpG 
sites. B) Left: non-methylated cytosine. Right: methylated cytosine. 
 
State of the art 
Numerous studies have found an association between DNA methylation 
modifications and depression. Epigenome-wide Association Studies (EWAS) 
located numerous CpG sites presenting significantly differentiated methylation 
in depressed patients, including hyper- and hypomethylations. BDNF, NR3C1, 
SLC6A4 and OXTR genes were the most frequently studied genes. Mostly, 
promoter regions and CpG islands were commonly targeted [11]. In addition, it 
has been suggested that many of the methylation differences in patients 
showing depressive symptoms are specially annotated to genes linked to a G-
protein coupled receptor protein signalling pathway [12]. 
 
1.1.3 Problem to solve 
DNAm in MDD is associated with socioeconomic factors but has not yet been 
used to discriminate depressive individuals from individuals without depressive 
symptoms. Since has been proven a discrepancy between objective and 
subjective cognition in MDD patients [13], it is necessary to find a system to 
detect the disease from a biological perspective. This project intends to create 
an algorithm-based tool to assess whether patients show depressive symptoms.  
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1.2 Objectives 
1.2.1 General objective 
Design, development and implementation of an algorithm to assess whether 
patients show depressive symptoms based on socioeconomic data and DNA 
methylation signatures in depression found in literature.  
 
1.2.2 Specific objectives 
1. To describe the subject and the state of the art. 
2. To extract and prepare the data from a published cohort that contains 
information in socioeconomic features and DNA methylation profiles.  
3. To perform a descriptive statistical analysis of the data.  
4. To find differentially methylated CpGs between samples presenting 
depressive symptoms versus samples not presenting those symptoms.  
5. To design, to develop and to validate the algorithm.  
6. To design a website where external data can be analyzed by the 
algorithm.  
 
 
1.3 Approach and follow-up method 
A possible approach in the development of this Project would be to take 
samples and perform socioeconomic and depression tests to a large random 
sample of the general population. Due to the lack of resources, an easier 
approach will be to find a published cohort that contains information in 
socioeconomic features (including the score of a validated depression scale) 
and methylation profiles.  
 
Moreover, after the analysis of the state of the art and the descriptive statistics 
of the data, a specific methodology will be selected, including an appropriate 
algorithm type. 
 
 
1.4 Work planning 
1.4.1 Necessary resources 
For the development of this project it is necessary to have a computer with 
internet connection and the following software installed:  
• Statistical software R, with the packages mentioned in Table 3.   
• Word processor. 
• Web browser.  
 
1.4.2 Tasks 
In Table 2 are shown the planned tasks for each specific objective with their 
respective expected time period. 
 
Objectives Tasks Period 
1. To describe the subject and the 
state of the art. 
• Task 1: Analyze bibliography and 
write a short introduction and 
summary of the state of the art. 
15/10/19 
to 
22/10/19 
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2. To extract and prepare the data 
from a published cohort that 
contains information in 
socioeconomic features and DNA 
methylation profiles.  
• Task 2: Extract data from a 
published cohort. 
23/10/19 
to 
25/10/19 
• Task 3: Pre-process the data. 26/10/19 
to 
29/10/19 
3. To perform a descriptive statistical 
analysis of the data.  
• Task 4: Perform descriptive 
statistics of the data. 
26/10/19 
to 
29/10/19 
4. To find differentially methylated 
CpGs between samples presenting 
depressive symptoms versus 
samples not presenting those 
symptoms.   
• Task 6: Perform differential DNA 
methylation analysis. 
30/10/19 
to 
02/11/19 
5. To design, to develop and to 
validate the algorithm.  
• Task 7: Design and implement 
the algorithm. 
03/11/19 
to 
18/11/19 
• Task 8: Improve the algorithm. 19/11/19 
to 
05/12/19 
6. To design a web application where 
external data can be analyzed by the 
algorithm. 
• Task 9: Design the web 
application.  
 
06/12/19 
to 
16/12/19 
Table 2. Specific objectives of the project with their respective tasks and timing for each 
task. 
The initial work plan had an extra task for specific objective 1: to find the DNA 
methylation signatures in depression identified in literature. The intention was to 
develop the algorithm from a database including, for each sample, 
socioeconomic and biomolecular data together with the DNA methylation values 
(M values)1 from the found DNA methylation signatures in depression. But the 
problem was that the resolution of the array used in the methylation data 
extraction from the selected published cohort is different than other studies. It 
was the Illumina Infinium HumanMethylation27 Beadchip v1.2, which covers 
27,578 CpG sites per sample, while the published studies from last years, used 
Illumina Infinium HumanMethylation450 Beadchip, which covers 482,421 CpG 
sites. For this reason, the majority of the significant found CpG sites were not 
available in the cohort data. 
 
A possible solution to this problem would have been to find another published 
cohort, but it was not possible to find another dataset meeting all the 
requirements to perform the planned algorithm. Thus, the new approach was to 
add a new task during the first phase of the project development: to perform a 
differential methylation analysis in the selected dataset to find the significant 
CpGs differentially methylated between the samples presenting depression 
                                            
1 Estimate of the methylation level, calculating the log2 ratio of the intensities of methylated 
probe versus unmethylated probe [50]). 
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symptoms versus the samples not presenting those symptoms according to the 
CES-D scale score. Further information about the CES-D scale is given in the 
materials and methods section.  
 
1.4.3 Calendar 
 
Figure 2. Phases, tasks and milestones of the project collected on a Gantt Chart. 
 
1.4.4 Milestones 
PEC 0:  
• Project contents report 
 
PEC 1:  
• Work plan  
 
PEC 2:  
• Summary of the subject and state of the art 
• Descriptive statistics report 
• Differential DNA methylation analysis 
• First version of the algorithm 
 
PEC 3: 
• Last and improved version of the algorithm 
• Web application 
 
PEC 4: 
• Final report 
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1.5 Brief summary of the obtained products 
1. Work plan 
2. Algorithm to assess whether patients show depressive symptoms 
3. Web application to perform the algorithm 
4. Final report 
5. Virtual presentation 
6. Auto evaluation 
 
 
1.6 Brief description of the other chapters of the report 
Other chapters in the memory have the following contents: 
• Chapter 2: Materials and methods 
In this section, the selected published dataset and the computational 
tools used in this project are detailed. Also, the necessary methodology 
to fulfil the goals of the project and the followed pipeline is described.  
 
• Chapter 3: Results 
Here, the methodology outcomes are described and presented: statistical 
analysis of the dataset, differential DNA methylation analysis, machine 
learning algorithm and web application.  
 
• Chapter 4: Discussion 
An interpretation of the results is presented, highlighting the most 
important findings and a comparison of those with literature knowledge.  
 
• Chapter 5: Conclusions 
A small summary of the project outcome, collecting the most important 
facts extracted from the results and discussion.  
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2. Materials and Methods 
 
2.1 Software 
The software used to analyze the data is the statistical software R (R-Studio 
interface) in its latest version at the time of this project, which is 3.5.3. 
 
The packages used are presented in the following table: 
 
Package Description Reference 
Biobase This package contains standardized data 
structures to represent genomic data that are 
used by other R packages. 
[14] 
caret The caret package (short for Classification And 
REgression Training) is a set of functions that 
attempt to streamline the process for creating 
predictive models. 
[15] 
GEOquery GEOquery is the bridge between Bioconductor 
and the public repository of microarray data Gene 
Expression Omnibus (GEO). 
[16] 
ggplot2 ggplot2 is a system for declaratively creating 
graphics, based on The Grammar of Graphics. 
[17] 
glmnet Efficient procedures for fitting the entire lasso or 
elastic-net regularization path for linear 
regression. 
[18] 
grid A rewrite of the graphics layout capabilities, plus 
some support for interaction. 
[19] 
gridExtra  Provides a number of user-level functions to work 
with “grid” graphics, notably to arrange multiple 
grid-based plots on a page, and draw tables. 
[20] 
limma Data analysis, linear models and differential 
expression for microarray data. 
[21] 
MASS Functions and datasets to support Venables and 
Ripley “Modern Applied Statistics with S” (4th 
edition, 2002). 
[22] 
moments Functions to calculate: moments, Pearson’s 
kurtosis, Geary’s kurtosis and skewness. 
[23] 
randomForest Classification and regression based on a forest of 
trees using random inputs. 
[24] 
reshape2 Facilitates to transform data between wide and 
long formats. 
[25] 
Table 3: R packages used during the performance of the project. 
 
2.2 Data 
The applied dataset was extracted from a published study [26] and was 
uploaded at the GEO database [27], an international public repository that 
archives and distributes functional genomics datasets free of charge. The 
dataset is registered under the access number: GSE37008.   
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In the original study, the data was collected from a community-based cohort 
stratified for early-life SES. The genomic DNA of 94 individuals was extracted 
from periferial blood mononuclear cells, bisulphite converted and hybridized, 
along with 5 technical replicates to the Illumina Infinium HumanMethylation27 
Beadchip v1.2 for genome wide DNA methylation profiling. This array measures 
the DNA methylation in the promoter regions of more than 14.000 human 
genes. 
 
The existence of depressive symptoms in the individuals of the cohort is 
screened by the CES-D scale. This scale measures symptoms defined by the 
DSM-V for a major depressive episode (Table 1). The possible range of scores 
is 0-60, with the higher scores indicating the presence of more symptomatology 
[28]. The common cut-off to assess the existence of depressive symptoms is 
16. 
 
 
2.3 Algorithm 
Random Forest (RF) algorithm was used to build the model. RF is an ensemble 
tool based on decision trees which allows to obtain a fast and reproducible 
classification predictor [24]. A defined number of trees using selected features 
(in this case, the phenotype variables and the selected CpG markers) lead to 
the prediction of the existence of depression symptoms based on the average 
estimation of each tree. Random sub-setting of samples within the training set 
for construction of each tree avoids overfitting to the training set samples. Here 
the RF algorithm was implemented with the RandomForest package (v.4.6-14).  
 
 
2.4 Web development 
The web application was written in HTML, PHP and CSS code and hosted at 
000webhost web server.  
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2.5 Pipeline 
 
Figure 3. Workflow of the project. 
Bibliography analysis
Data extraction and 
preparation 
Descriptive statistics 
analysis
Differential DNA 
methylation analysis
Design and implementation 
of the algorithm
Design and implementation 
of the web application
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3. Results 
 
3.1 Descriptive statistics 
3.1.1 Extraction of the data  
The data was downloaded with the function getGEO() from the package 
GEOquery, using the GEO accession number (GSE37008). The M values were 
already normalized. The phenotype data was extracted as a data frame with the 
function pData() from the package Biobase. 
 
3.1.2 Data analysis 
The phenotype dataset contains a total of 99 observations (samples) and 39 
variables (features). The variables can be divided in socioeconomic (Table 4) 
and biomolecular (Table 5).  
 
Socioeconomic variables Unit 
age years 
gender Female / Male 
smoker Yes / No 
SES in early life High / Low 
SES at present time High / Low 
alcohol drinks per week 
body mass index (BMI) kg/m2 
exercise minutes per week 
stress Perceived Stress Scale questionnaire 
depression Center for Epidemiologic Studies Depression Scale 
sleep perceived quality; Pittsburgh Sleep Quality Index 
birth control current use of oral contraceptives 
ethnicity Caucasian or other ethnicity 
pbifw measures of recalled paternal warmth based on the 
questionnaire Parental Bonding Index 
pbimw measures of recalled maternal warmth based on the 
questionnaire Parental Bonding Index 
Table 4. Socioeconomic variables of the phenotype data from the GSE37008 dataset. 
 
Biomolecular variables Unit 
total cortisol total cortisol release over 3 days in arbitrary units 
dslope diurnal rhythm of cortisol in arbitrary units 
pam3csk4 Interleukin-6 (IL-6) response to pam3csk4 in pg/ml 
pgn IL-6 response to peptidoglycan in pg/ml 
pic IL-6 response to ppoly i:c in pg/ml 
lps IL-6 response to lipopolysaccharide in pg/ml 
flagellin IL-6 response to flagelin in pg/ml 
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zymosan IL-6 response to zymosan in pg/ml 
ssr IL-6 response to single-stranded RNA in pg/ml 
imiquimod IL-6 response to imiquimod in pg/ml 
odn IL-6 response to oligodeoxyribonucleotide in pg/ml 
il1b IL-6 response to interleukin-1b in pg/ml 
pma IL-6 response to phorbol-12-myristate-13-acetatein in 
pg/ml 
wbc count total white blood cells x 109 / liter blood 
neutrophils neutrophils x 109 / liter blood 
lymphocytes lymphocytes x 109 / liter blood 
monocytes monocytes x 109 / liter blood 
basophils basophils x 109 / liter blood 
eosinophils eosinophils x 109 / liter blood 
neutrophil% percent of wbc that are neutrophils 
lymphocyte% percent of wbc that are lymphocytes 
monocyte% percent of wbc that are monocytes 
basophil% percent of wbc that are basophils 
eosinophil% percent of wbc that are eosinophils 
Table 5. Biomolecular variables of the phenotype data from the GSE37008 dataset. 
The biomolecular variables total.cortisol and dslope were discarded due to a 
high amount of missing values, which reduced the number of incomplete 
samples from 27 to 9. The remaining 9 samples with missing values 
(GSM908398, GSM908418, GSM908419, GSM908429, GSM908430, 
GSM908446, GSM908455, GSM908456 and GSM908474), together with the 4 
samples not containing methylation data (GSM908432, GSM908438, 
GSM908440 and GSM908461), were also discarded. The final dimensions of 
the phenotype dataset were 86 observations and 37 variables. 
 
3.1.3 Graphic analysis 
The variables were divided in 4 groups to perform their individual graphic 
representation: quantitative socioeconomic variables (Figure 4), categorical 
socioeconomic variables (Figure 5), quantitative biomolecular variables (Figure 
6) and categorical biomolecular variables (Figure 7). In the first group, the 
predictive variables showing a correlation with the response variable depression 
were stress (p-val = 8.12·10-20) and pbifw (p-val = 0.0194). In the second group, 
the biggest correlations are for the variables smoker, current SES and sleep. In 
the biomolecular variables group, the correlated predictive variables with the 
response variable were pam3csk4 (p-val = 0.0217) and odn (p-val = 0.0301). 
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Figure 4. Linear regression plots of quantitative 
socioeconomic predictor variables against response 
variable depression. 
 
 
Figure 5. Boxplots of categorical socioeconomic predictor variables against 
response variable depression. 
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Figure 6. Linear regression plots of biomolecular predictor variables against response 
variable depression. 
 
Figure 7. Boxplots of categorical biomolecular 
predictor variables against response variable 
depression. 
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3.1.4 Analysis of the response variable depression 
The response variable is a quantitative variable representing the CES-D score. 
In this dataset it ranges from 0 to 45 points, with an average of 13.17 and a 
median of 10.00. Since average and median are different, it was necessary to 
study this variable to assess its normality.  
 
Figure 9-A shows the density of the response variable, and it seems that the 
distribution is clearly asymmetric, with a skewness of 1.077. To correct the 
asymmetry, the Box-Cox correction method was applied with the package 
MASS. It was necessary to add a small constant (1·10-5) to the response 
variable before calculating the lambda value due to the presence of zeros in the 
variable. 
 
Figure 8. Log-likelihood plot for Box-Cox response 
variable depression transformation. 
The variable was corrected with the parameter =0.5 (Figure 8). 
 
Figure 9. Comparision between response variable depression before (A) and after 
(B) Box-Cox transformation. 
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After the application of the Box-Cox correction, the skewness decreased to 
0.126. 
 
3.1.5 LASSO linear regression to identify most significant phenotype variables 
Although all the socioeconomic and biomolecular features will be used to the 
development of the algorithm, a LASSO model was constructed to pinpoint the 
significant variables. First of all, model matrix of the predictor variables was 
created. The function gv.glmnet() was used to find the best lambda for the 
model, identifying =0.2. The function glmnet() was then used to build the 
model. The predictive variables selected as significant by the LASSO model 
were: smoker, current SES, stress and lps. 
 
 
3.2 Differential DNA methylation analysis 
For this analysis the Linear Models for Microarrays method, implemented in the 
limma package [21] is used to select differentially methylated CpGs. 
 
3.2.1 Data preparation 
The methylation values were extracted with the function exprs() from the 
package Biobase. The dataset contains a total of 27,578 observations (M 
values) and 99 variables (samples). The incomplete samples mentioned in the 
previous section (9 samples with missing values within the phenotype data and 
4 samples without methylation data) were removed. Afterwards, there were 
identified empty 4,656 observations, which were as well eliminated. The final 
dimensions of the methylation dataset were 22,578 observations and 86 
variables. 
 
The samples were divided in four groups: control female (Group 0) for females 
with a CES-D score under 16, control male (Group 1) for males with a CES-D 
score under 16, depressed male (Group 2) for males with a CES-D score equal 
or above 16, and depressed female (Group 3) for females with a CES-D equal 
or above 16. 
 
3.2.2 Principal Components Analysis (PCA) 
In order to do a first exploratory analysis of the data, a PCA was performed.  
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Figure 10. PCA plot for the first two principal components (PC). 
The conclusion was that the accountability for the total variability of the samples 
was widely distributed. First component of the PCA accounts for 15% of the 
total variability, and second component accounts for a 9.3%. For this reason, at 
the plot of the first two components it was not possible to observe big 
differences between groups.  
 
3.2.3 Design matrix 
A design matrix was created, in order to describe the allocation of each sample 
to its group. The variable age was added as a covariate to the model due to the 
known chronological age-dependent changes in methylation [29]. Table 6 
shows the first 10 observations of the design matrix for this analysis.  
 G0 G1 G2 G3 age 
GSM908383 1 0 0 0 38 
GSM908384 0 1 0 0 26 
GSM908385 1 0 0 0 33 
GSM908386 0 1 0 0 38 
GSM908387 0 1 0 0 37 
GSM908388 0 0 0 1 31 
GSM908389 1 0 0 0 38 
GSM908390 0 0 0 1 37 
GSM908391 0 1 0 0 31 
GSM908392 1 0 0 0 30 
Table 6. First 10 samples of the design 
matrix for the differential methylation 
analysis.  
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3.2.4 Contrasts Matrix 
The comparisons between groups were defined by the contrasts matrix (Table 
7). In this case, the goal was to check the effect of depression (“depressed vs 
control”) separately for both genders. 
 G3 - G0 G2 - G1 G1 - G0 G3 - G2 
G0 -1 0 -1 0 
G1 0 -1 1 0 
G2 0 1 0 -1 
G3 1 0 0 1 
age 0 0 0 0 
Table 7. Contrasts matrix for the differential 
methylation analysis. 
The contrast matrix was defined to perform four comparisons: effect of 
depression in females (G3 - G0), effect of depression in males (G2 - G1), effect 
of gender in controls (G1 - G0) and effect of gender in depressed (G3 - G2). 
 
3.2.5 Model estimation and CpG selection 
Once the model and the contrasts were estimated, and the significance tests 
were performed, a list of the differentially methylated CpG motifs was obtained. 
The list was ordered from smallest to biggest p-value, and the observations with 
the p-value over 0.05 were eliminated. The total number of selected CpG was 
31, which were annotated with the available data in the GEO ExpressionSet 
applying the function fData() to the initial ExpressionSet object (Table 8).  
 
ID adj.P.Val Chr Gene_Strand Gene_ID Symbol 
cg23758485 5.53E-15 16 - GeneID:55512 SMPD3 
cg18485485 5.53E-15 8 + GeneID:1666 DECR1 
cg16718678 5.53E-15 11 - GeneID:9379 NRXN2 
cg09067967 8.57E-09 4 - GeneID:7358 UGDH 
cg13913917 0.000118 3 + GeneID:23200 ATP11B 
cg02058918 0.0009 9 - GeneID:9568 GABBR2 
cg20050113 0.001585 2 + GeneID:6549 SLC9A2 
cg00798206 0.001585 3 + GeneID:9943 OXSR1 
cg14912575 0.001953 14 - GeneID:56936 C14orf162 
cg08590939 0.003394 5 - GeneID:5019 OXCT1 
cg23552468 0.003714 9 + GeneID:138724 MGC41945 
cg14464791 0.005554 11 - GeneID:1656 DDX6 
cg00234616 0.006183 2 + GeneID:3196 TLX2 
cg18329349 0.008854 7 + GeneID:857 CAV1 
cg22584138 0.017207 17 - GeneID:6532 SLC6A4 
cg08532057 0.017207 13 + GeneID:9818 NUPL1 
cg10164137 0.017928 1 - GeneID:1855 DVL1 
cg08124399 0.022535 6 + GeneID:55510 DDX43 
cg08085267 0.022535 17 + GeneID:124989 C17orf57 
cg08832227 0.022625 12 + GeneID:3736 KCNA1 
cg09354267 0.025742 6 - GeneID:9474 ATG5 
cg11787522 0.025742 15 - GeneID:64220 STRA6 
18 
cg25664034 0.027517 7 + GeneID:2318 FLNC 
cg22631938 0.041012 3 + GeneID:2850 GPR27 
cg03311036 0.041012 7 + GeneID:835 CASP2 
cg18022322 0.042035 14 + GeneID:22990 PCNX 
cg00425710 0.042035 16 + GeneID:4489 MT1A 
cg15446391 0.04664 11 - GeneID:7490 WT1 
cg09886641 0.04664 15 + GeneID:246777 SPESP1 
cg14576824 0.04664 1 + GeneID:26750 RPS6KC1 
cg27167601 0.048736 15 - GeneID:6095 RORA 
Table 8. List of the differentially methylated CpG sites in depression with a p-value under 
0.05. 
 
3.2.6 Graphic representation of the differentially methylated CpG sites 
In order to visualize the M values of the CpG sites which methylation levels are 
significantly differentiated in depression, they were plotted (Figure 10). 
 
 
Figure 11. M values of the selected 31 CpG sites with a p-value < 0.05 for the 
differential analysis, differentiating between depressed and not depressed samples. 
 
3.3 Machine learning algorithm 
 
3.3.1 Initial model 
A new dataset was created, joining for each sample the phenotype variables 
with the M values for the differentially methylated CpG sites. It contained a total 
of 86 observations (samples) and 68 variables (15 socioeconomic, 22 
biomolecular and 31 CpG M values). The variable depression containing the 
CES-D scores was substituted by a categorical variable with the group 
classification, and the categorical variables (smoker, current SES, birth control 
and ethnicity) were changed to binary factors.  
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The dataset was randomly divided into a train dataset with 57 samples (67%) 
which was used to train the model, and a test dataset with 29 samples (33%) 
which was used to evaluate the model. 
 
Model training with the data 
The model was trained using the function randomForest() from the package 
with the same name. For the initial model, the parameters ntree (number of 
trees produced by the algorithm) and mtry (number of randomly selected 
variables as candidates in each division) were the function default ntree = 500, 
and mtry = 8. Figure 12 shows the plot of the obtained model.  
 
 
Figure 12. Error evolution of the model created by Random Forest algorithm for 
ntree=500 and mtry=8. 
 
Model performance evaluation 
With the aim of evaluating the performance of the model, the test dataset 
samples were classified in one of the four groups using the function predict(). 
The predictions were compared to the real labels of each sample through a 
confusion matrix (Table 9) using the function confusionMatrix() from the caret 
package. 
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  Reference 
  
control 
female 
control 
male 
depressed 
male 
depressed 
female 
P
re
d
ic
ti
o
n
 
control 
female 
13 1 0 1 
control 
male 
0 5 3 0 
depressed 
male 
0 0 1 0 
depressed 
female 
0 0 0 5 
Table 9. Confusion matrix of the predicted classification versus 
the real labels of the test samples. 
For the group control female, all the 13 samples were classified correctly. For 
the group control male, five samples were classified correctly but one of the 
samples was wrongly identified as control female. This means that there were 
no false positives regarding the disease condition, only one wrongly identified 
gender. On the other hand, for the group depressed male, only one sample was 
classified correctly, and three samples were classified as control male (false 
negative). For the group depressed female, five samples were classified 
correctly and one sample was wrongly classified as control female (false 
negative). Thus, the model has a very good specificity but an insufficient 
sensitivity differentiating patients showing depressive symptoms. 
   
Statistics: 
The model had an accuracy of 82.76%, with a confidence interval at 95% 
between 64.23 and 94.15% (p-value = 3.119·10-5) and Kappa = 74.29%, which 
indicates on average a good agreement between the model predictions and the 
true values.  
 Class 
 control female control male depressed male depressed female 
Sensitivity 1.0000 0.8333 0.25000 0.8333 
Specificity 0.8750 0.8696 1.00000 1.0000 
Table 10. Sensitivity and specificity of the model by class. 
 
3.4 Algorithm tuning 
Once the model is built, it is necessary to tune the algorithm in order to achieve 
the best performance for the specific model but avoiding overfitting. There are 
two main parameters to be tuned in the RF algorithm: the mtry parameter, 
which is the number of variables randomly sampled as candidates at each split 
and the ntree parameter, which is the number of trees to create. In this project, 
different tuning methods involving the adjustment of the mentioned parameters 
were tried [30]. 
 
3.4.1 Tuning mtry while holding ntree constant 
The caret package provides the function train() for algorithm tuning, although 
only mtry parameter adjustment is available for the RF algorithm. The ntree 
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value will stay constant at its default ntree = 500. Both applied search methods 
to find the best value for mtry with caret were adjusted to do a 15-fold cross-
validation and 3 repeats to limit and reduce overfitting on the training set. The 
accuracy value was used to select the optimal model. 
 
Random search 
For the random search, performing a total of 30 trials, the best mtry value was 
29, with an accuracy of 72.64% and Kappa = 59.36%. Figure 13 shows a plot of 
the different obtained accuracies for the randomly used mtry values. 
 
 
Figure 13. Results for the RF tuning with random search from caret package. 
 
Grid search 
For the grid search, trying a total of 30 mtry values (from 1 to 30), the best mtry 
was 24 with an accuracy of 73.97% and Kappa = 61.28%. Figure 14 shows a 
plot of the different obtained accuracies for the 30 tried mtry values. 
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Figure 14. Results for the RF tuning with grid search from caret package. 
 
3.4.2 Tuning ntree while holding mtry constant 
To overcome the disadvantage of the caret package regarding the ntree 
parameter tuning, several caret models were created and compared. For this 
approach, the mtry parameter is maintained constant at the square root of the 
number of variables. In this case, mtry = 8. A total of 6 models with different 
values for ntree were analyzed (500, 1000, 1500, 2000, 2500 and 3000). 
 
Figure 15. Representation of Accuracy and Kappa scores for the caret models with 
different values for the parameter ntree. 
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3.4.3 Tuning both ntree and mtry parameters simultaneously 
The last approach was customizing the train() function from the caret package 
used in the previous methods, to allow the simultaneous adjustment for both 
ntree and mtry parameters. Thus, instead of using the default “rf” method, new 
algorithm parameters and functions needed to be defined in an R list. The R list 
was later specified in the method parameter of the train() function to try different 
values of ntree and mtry.  
 
The tried values were: 
− mtry: from 1 to 66 (all possible values). 
− ntree: 1000, 1500, 2000, 2500 and 3000. 
The results can be visualized in Figure 16. The best values for the parameters 
mtry and ntree adjusted simultaneously by a customized method were mtry = 
17 and ntree = 2500, and the model had an accuracy of 73.74% and Kappa = 
60.82% 
 
 24  
 
Figure 16. Results for the RF tuning with customized method for both ntree and mtry parameters adjustment simultaneously.
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3.4.4 Final model 
Finally, the best tuning values (mtry = 24, ntree = 500) were tried in a single 
model. 
 
Model performance evaluation 
With the aim of evaluating the performance of the model, the test dataset 
samples were classified in one of the four groups using the function predict(). 
The predictions were compared to the real labels of each sample through a 
confusion matrix (Table 11) using the function confusionMatrix() from the caret 
package. 
  Reference 
  
control 
female 
control 
male 
depressed 
male 
depressed 
female 
P
re
d
ic
ti
o
n
 
control 
female 
13 0 0 0 
control 
male 
0 6 0 0 
depressed 
male 
0 0 4 0 
depressed 
female 
0 0 0 6 
Table 11. Confusion matrix of the predicted classification versus 
the real labels of the test samples. 
For this individual model, all the samples of the four groups were classified 
correctly.  
   
Statistics: 
The model had an accuracy of 100%, with a confidence interval at 95% 
between 88.06 and 100% (p-value = 7.849·10-11) and Kappa = 100%, which 
indicates on average an outstanding agreement between the model predictions 
and the true values.  
 
Variable importance for the final model 
In order to analyze the most important variables in the final model, the variable 
importance was plotted (Figure 17) with the function varImpPlot() from the 
randomForest package. The plot represents the mean decrease in accuracy2 
for the variables with a biggest value for this mean. In the plot, it is possible to 
appreciate that the most important variables (with a mean decrease accuracy 
over 10) for the final model are stress, cg16718678 (NRXN2 gene), 
cg18485485 (DECR1 gene) and cg23758485 (SMPD3 gene). 
 
 
 
 
 
 
                                            
2 The mean decrease in accuracy refers to the number or proportion of observations that are 
incorrectly classified by removing the feature in question from the model. 
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Figure 17. Variable importance plot for the depressive symptoms RF classifier for the 20 
variables with highest mean decrease accuracy.   
 
 
3.5 Web application 
A web application was developed for public use of the algorithm. The web was 
programmed in HTML / PHP and has two options to introduce the necessary 
patient data to return a prediction, by filling a form or uploading a csv file. It was 
necessary to create the following files: 
1. HTML files 
1.1. Index (Figure 18): contains the home page of the web application, with a 
short description of the algorithm and one link for each data introduction 
option. 
1.2. Form (Figure 19): if the selected method for introducing data is by a 
form, the user will be conducted to this page, which contains a formulary 
to be filled with the patient data. Once the data is introduced and 
submitted, the user will be directed to the PHP form results. 
1.3. Upload (Figure 20): if the selected method for introducing data is by 
uploading a csv file, the user will be conducted to this page and will be 
able to browse in their machine for the file containing the patient data 
and upload it. The csv file must contain all the variables for the patient 
data in a single row, ordered as specified in the web page and 
separated by commas. Once the file is submitted, the user will be 
directed to the PHP upload results. 
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Figure 18. Home page of the web app developed to predict the existence of depressive 
symptoms.   
 
 
Figure 19. Form page of the web app where the user can fill in the patient data. 
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Figure 20. Uploading page of the web app where the user can upload a file containing the 
patient data.   
 
2. CSS file: contains the styles of the web app (font size, background image, 
colour, ...) 
3. CSV file: a for loop together with the function getTree() from the package 
randomForest in R was used to extract each tree from the final model forest. 
Each tree is a matrix containing the structure of one individual decision tree. 
All the matrixes were bound together and saved in a csv file. 
4. PHP files 
4.1. Random forest algorithm: a file defining the classes for individual tree 
branches, for trees and for the entire forest, which will point the pathway 
to make decisions using the forest: while asking for a result, it will loop 
through all the trees in the forest making a prediction for each tree. The 
most frequent answer will be the prediction of the algorithm [31]. 
4.2. Form results: after submitting the HTML form, this file will collect all the 
fields of the form into an array, load the random forest algorithm file, and 
run the prediction using the forest from the csv file. The process will 
direct to a results page (Figure 21). 
4.3. Upload results: after submitting the HTML upload, it will collect the data 
from the file into an array and it will follow the same steps than in the 
forms result file. 
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Figure 21. Results page. In the left, capture of the results page when the loaded sample is 
a probable case of depression. In the left, capture of the results page when the loaded 
sample is a probable healthy patient. 
 
All the files contents are available in annexes.  
 
During the development of the web app, the files were tested by a local host 
using XAMPP. Once all the files were ready, they were uploaded into the 
000webhost server to create the website, and it was hosted under the address 
http://desypre.000webhostapp.com/.  
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4. Discussion 
 
4.1 Stress, current SES, cigarette smoking and IL-6 response to 
lipopolysaccharid is correlated with depressive symptomatology 
The individual linear regression models showed a strong positive correlation 
between depression and stress (p-val = 8.12·1020), that was already evidenced 
in the literature [32]. There were two other relationships found in this project: 
low current SES with depressive symptomatology and cigarette smoking with 
MDD, both are also supported by previous studies [33] [34]. 
 
Regarding to IL-6 response to lipopolysaccharid, Moieni et al. stated that the 
change in IL-6 following LPS administration it is positively correlated with 
depression-related symptoms in women, but not in men  [35]. This fact explains 
the correlation in the studied cohort, but further analysis would be needed to 
analyse the differences between genders. 
 
Since there is a relation between socioeconomic and biomolecular factors and 
depression, new studies need to be done for DNA methylation in depression 
with a larger cohort and well defined socioeconomic factors. 
 
 
4.2 Thirty-one differentialy methylated CpG loci associated with depression 
The differential methylation associated with depression is widely spread 
throughout the genome and here it was possible to differentiate 31 CpG sites 
influencing the appearance of depressive symptoms in the studied cohort, being 
the most significant CpGs: cg23758485 in gene SMPD3, cg18485485 in gene 
DECR1, cg16718678 in gene NRXN2 and cg09067967 in gene UGDH. 
 
CpG cg23758485 is known to be differentially methylated by sex in humans, 
with a higher methylation in females than in males [36]. There are no previous 
publications showing a direct association between SMPD3 and depression, but 
a recent study found that SMPD3 deficiency perturbs neuronal proteostasis in 
mouse [37], which could be a starting point to search for other primary 
pathogenic mechanisms. Moreover, the Comparative Toxicogenomics 
Database Gene-Disease Associations contains a curated association between 
SMPD3 and depressive disorder mediated by several toxins (arsenic, bisphenol 
A, dietary fats, estradiol, ...) [38]. 
 
The dataset SNP-Phenotype Associations from GWASdb, a database for 
human genetic variants, identified by genome-wide association studies [39], 
associates DECR1 as one of the 2.466 genes associated with the depression 
phenotype, but no more further information was found about this association in 
literature. 
 
Regarding NRXN2, Born et al. validated the exhibition of behavioural 
abnormalities, characterized by social interaction deficits and increased anxiety-
like behaviour, in mice lacking Nrxn2α [40], which corresponds with part of the 
depression symptomatology in humans. 
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No connexion could be found in literature between UGDH and depression. 
However, it has been mentioned a gender-based differential regulation in 
various diseases like breast cancer [41], and its expression is known to be 
stimulated by androgen, a male sex hormone [42]. Thus, it could be a candidate 
to performing further studies of the association of UGDH with the gender 
differences in depression. 
 
Other connections were found for some of the other differentially methylated 
CpG sites in this analysis. A methylome-wide association study (MWAS) 
performed by Aberg et al. identified the GABBR2 gene as a candidate to be 
associated with MDD [43].  A recent study found SLC9A2 gene not only to be 
related with depression, but as well with suicide in patients with MDD [44]. The 
gene OXCT1 has been related with schizophrenia, bipolar disorder and 
depression [45]. The loci cg22584138 is located at the SLC6A4 gene, one of 
the most studied genes associated with depression [11], which is responsible 
for serotonin re-uptake, known to be often disrupted in depression [46]. TLX2 
has been associated with differential regulatory mechanisms in untreated MDD 
patients [47]. Wilkinson et al. stated that brain tissue from both mice models and 
post-mortem depressed humans showed downregulation of the DVL1-3 genes 
[48]. And as a last example, GWAS showed a strong association for depression 
in RORA gene, which is involved in circadian rhythm [49]. 
 
Even though the results of this analysis gave new candidate CpG sites 
associated with depression and confirmed some others already known in 
literature, it could still be improved applying the pipeline designed from this 
differential methylation analysis to a larger dataset (with more observations) and 
using an array with higher resolution (higher number of CpG sites).  
 
 
4.3 RF algorithm to identify patients showing depressive symptoms 
The RF algorithm resulting from the training with the selected variables 
(socioeconomic, biomolecular and 31 CpGs) predicts if a patient presents 
depressive symptoms with an accuracy of 100% with a CI at 95% between 
88.06 and 100% (p-value = 7.849·10-11) for a test subsample of the studied 
cohort containing 29 samples, and 73.97% for a 15-fold cross-validated with 
three repeats model. The parameters of the algorithm were set at mtry = 24 and 
ntree = 500. 
 
To reach the highest accuracy for the test model it was necessary to find the 
best combination of values for both mtry and ntree. Regarding the mtry tune 
with the default value for ntree, the random and grid search showed a variable 
accuracy while increasing mtry value, being lower in the extremes. For the ntree 
tune with the default value for mtry, the best accuracy is obtained in higher 
values of ntree. Tuning different combinations of mtry and ntree does not obtain 
an improved accuracy compared to the best found at the mtry tune with a 
default ntree (mtry = 24 and ntree = 500), which was used in the final test 
model. 
 
The accuracy from the cross-validated model could be improved using a larger 
population, since the only found publically available dataset containing 
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methylation data together with socioeconomic data and including depression 
status or score only contains 94 observations. A further improvement of a future 
cohort would be the depression assessment by different depression scales to 
improve the previous classification of the patients. However, the pipeline 
designed for this project could be easily applied to future datasets to generate 
an improved algorithm.  
 
 
4.4 Desypre, the new tool to detect depression symptoms 
Desypre is an online tool addressed to medical doctors in clinical environments 
to be used as an objective depressive symptoms predictor. To use it, the doctor 
will need a methylation analysis for the 31 target CpG sites, a blood test 
analysis containing IL-6 response to different components and blood cells 
count, the Perceived Stress Scale and the Parental Bonding Index scores, and 
the socioeconomic data of the patient. 
 
The clinical implications of this tool are that early screening of those at risk for 
MDD may be possible and from an objective approach, allowing an earlier 
direction of clinical treatment course. 
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5. Conclusions 
 
This project has developed a RF-based prediction tool for depressive symptoms 
from socioeconomic, biomolecular and differential DNA methylation features. 
During the development process, it has been found that stress, current SES, 
cigarette smoking and IL-6 response to lipopolysaccharid are correlated to 
depressive symptomatology. Also, 31 CpG had been found to be differentially 
methylated.  
 
Despite not being able to fully follow the initial planned pipeline, it has been 
possible to reach the final goal building the prediction tool with a different 
approach. Initially, the differentially methylated CpGs in depression were going 
to be identified in literature. But the cohort was analyzed with a low resolution 
array in which the main loci found in literature were not present. For this reason, 
it was necessary to perform a differential DNA methylation analysis, with which 
it was possible to identify 31 CpGs differentially methylated. 
 
Even though this project has obtained its goal outcome, it would be possible to 
improve it by using a larger cohort with different depression symptoms 
assessment methods. The pipeline of this project has been designed to be 
easily applicable to future cohorts. 
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4. Glossary 
 
BMI Body Mass Index 
CES-D Center for Epidemiologic Studies Depression scale  
CpG Cytosine Guanine dinucleotid 
DNAm DNA methylation 
DSM-V American Psychiatric Association Diagnostic and Statistical 
Manual (version V) 
EWAS Epigenome-Wide Association Study 
GEO Gene Expression Omnibus 
GWAS Genome-Wide Association Study 
IL-6 Interleukin-6 
MDD Major Depressive Disorder 
mtry Number of randomly selected variables as candidates in each 
division in a Random Forest algorithm 
MZ Monozygotic 
M values DNA methylation values 
ntree Number of trees produced in a Random Forest algorithm 
PC Principal Components 
PCA Principal Components Analysis 
RF Random Forest 
SES Socioeconomic Status 
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